Alembic Pharmaceuticals' (NSE:APLLTD, BOM:533573) consolidated profit rose to 1.54 billion Indian rupees in the fiscal first quarter ended June 30, against 1.35 billion rupees a year ago.
Earnings per share came in at 7.85 rupees compared with the 6.84 rupees a year earlier, the pharmaceuticals manufacturer said in a Tuesday filing to the Indian stock exchanges.
Revenue from operations in fiscal Q1 also increased to 17.1 billion rupees from 15.6 billion rupees a year ago.
The company's shares were down over 1% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。